BioTech/Drugs - #04-55 Singapore, N/A, sg
Incorporated in 2018, CytoMed Therapeutics is a spin-off from Singapore's Agency for Science, Technology and Research ( A*Star) and focuses on translating its patented technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based "off-the-shelf" immunotherapeutics for a wide range of cancers.We also engage in generating induced pluripotent stem cells (iPSCs) and translating them into "off-the-shelf" cellular therapeutics using our proprietary technologies for our customers.
Gmail
Apache
Google Font API
Mobile Friendly
YouTube